Apico-coronal Position of the Implant in Edentulous Diabetics With Implant-retained Overdentures
Could the Apico-coronal Position of the Implant Influence the Peri-implant Parameters in Mandibular Edentulous Type 2 Diabetics Rehabilitated With Implant-retained Overdentures? A Split-mouth RCT With 24-months Follow up.
1 other identifier
interventional
22
0 countries
N/A
Brief Summary
Diabetes Mellitus (DM) is a recognized factor affecting implant complication rates, including peri-implantitis and peri-implant bone loss, and the apico-coronal position of implants seems interfere on the conditions of peri-implant tissues. However, the influence of the vertical implant position in type 2 diabetics (T2DM) is unclear. This split-mouth randomized controlled trial evaluated the impact of implants of machined-collar placed at crestal level or supracrestally in T2DM rehabilitated with implant-retained overdentures on the clinical, tomographic and immunoinflammatory peri-implant outcomes after implant loading.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus
Started Nov 2014
Longer than P75 for not_applicable diabetes-mellitus
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 12, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 29, 2018
CompletedFirst Submitted
Initial submission to the registry
May 30, 2019
CompletedFirst Posted
Study publicly available on registry
June 17, 2019
CompletedJune 17, 2019
June 1, 2019
3.9 years
May 30, 2019
June 14, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline Peri-implant Probing Depth (PPD) at 24 months.
distance from the bottom of the peri-implant pocket (PPD) to the mucosal margin (MM) measured by a calibrated examiner in millimeter using a Periodontal probing
(baseline) and at 6, 12 and 24 months
Secondary Outcomes (6)
Mucosal Margin (MM)
(baseline) and at 6, 12 and 24 months
Clinical attachment level (CAL)
(baseline) and at 6, 12 and 24 months
Modified Bleeding on Probing
(baseline) and at 6, 12 and 24 months
Modified Plaque Index
(baseline) and at 6, 12 and 24 months
Crest Height Bone Marginal Peri-implant
(baseline) and at 6, 12 and 24 months
- +1 more secondary outcomes
Study Arms (2)
Implant placed at supra crestal level (SL)
EXPERIMENTALImplants were placed at supra crestal level (SL)
Implant placed at crestal level (CL).
OTHERImplants were placed at crestal level (CL)
Interventions
Surgeries to dental implant placement were performed. All patients received 3.5 mm diameter dental implants - surface blasted with TiO2 particles and machined collar of 1mm - in the interforaminal region of the mandible. The surgical sequence followed the protocol described by the implant company.A two stages protocol was used and the prostheses were placed at 4 months.The prosthetic retention system used in rehabilitation with overdentures was the O'ring and the capture of this component was done directly in the patient's mouth. After 7 and 14 days, the patients returned to occlusal adjustments and verification of prosthetic adaptation. The prostheses were made entirely of acrylic resin without metallic reinforcement and the antagonist of the patients were total edentulous and rehabilitated with muco-supported prostheses.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017; 128:40-50. GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390: 1260-1344. Kapur KK, Garrett NR, Hamada MO, et al. A randomized clinical trial comparing the efficacy of mandibular implant-supported overdentures and conventional dentures in diabetic patients. Part I: Methodology and clinical outcomes. J Prosthet Dent. 1998; 79: 555-569.
BACKGROUNDConte A, Ghiraldini B, Denofrio PHF, Marcello-Machado RM, Correa MG, Pimentel SP, Casati MZ, Pecorari VGA, Cirano FR. Supracrestal implant placement improves peri-implant health in T2DM patients: A randomized clinical trial. J Dent. 2025 Oct;161:106002. doi: 10.1016/j.jdent.2025.106002. Epub 2025 Jul 25.
PMID: 40716558DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Alexandre Conte
Paulista U
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 30, 2019
First Posted
June 17, 2019
Study Start
November 1, 2014
Primary Completion
September 12, 2018
Study Completion
October 29, 2018
Last Updated
June 17, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will not share